An underestimated comorbidity of COPD: Thyroid dysfunction.

Area of Science:

• Pulmonary Medicine
• Endocrinology

Background:

• Chronic obstructive pulmonary disease (COPD) presents numerous systemic effects impacting patient morbidity and mortality.
• Thyroid diseases are more prevalent in COPD patients, yet often underestimated despite significant clinical implications.

Purpose of the Study:

• To review the underrecognized thyroid dysfunctions in COPD patients.
• To explore the mechanisms and clinical outcomes associated with these comorbidities.

Main Methods:

• Literature review of studies examining thyroid dysfunction in COPD patients.
• Analysis of factors contributing to thyroid dysfunction in this population.

Main Results:

• Thyroid dysfunction, including hypothyroidism and hyperthyroidism, is more common in females with COPD.
• Factors such as systemic inflammation, hypoxia, age, glucocorticoid use, and smoking influence thyroid dysfunction development in COPD.

Conclusions:

• Thyroid dysfunctions are significant, underrecognized comorbidities in COPD.
• Understanding these links is crucial for comprehensive patient management and improving outcomes.